Marc Lustig - 01 Aug 2022 Form 3 Insider Report for BriaCell Therapeutics Corp. (BCTX)

Role
Director
Signature
/s/ Marc Lustig
Issuer symbol
BCTX
Transactions as of
01 Aug 2022
Transactions value $
$0
Form type
3
Filing time
02 Aug 2022, 16:07:59 UTC
Next filing
20 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BCTX Common Shares 1,640,000 01 Aug 2022 See Footnote 1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BCTX Warrant 01 Aug 2022 Common Shares 20,000 $5.31 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Registered in the name of L5 Capital Inc, an entity controlled by the reporting person.